GAD65 is a significant autoantigen in T1D, and studies have shown that vaccines based on GAD65 protein or plasmid DNA can prevent and mitigate T1D in non-obese diabetic (NOD) mice [9,10]. Here, GAD2 is linked to type 1 diabetes mellitus.